Published online Mar 6, 2026. doi: 10.12998/wjcc.v14.i7.117431
Revised: January 13, 2026
Accepted: February 2, 2026
Published online: March 6, 2026
Processing time: 88 Days and 15.9 Hours
Extrahepatic portal venous obstruction is a major cause of non-cirrhotic portal hypertension in children and young adults. It most commonly results from portal vein thrombosis. While prothrombotic states are recognized contributors, com
A 27-year-old male presented with an episode of melena and had a background of portal cavernoma cholangiopathy and recurrent variceal bleeding since infancy. Previously, he underwent endoscopic sclerotherapy and proximal lienorenal shunt surgery and later developed shunt thrombosis and ischemic biliary strictures requiring Roux-en-Y hepaticojejunostomy. Upper gastrointestinal endoscopy (UGIE) revealed large esophageal and gastric varices that were managed by endoscopic variceal ligation and sclerotherapy. Following the UGIE, he suffered a seizure with deterioration of sensorium, followed by melena and spikes in temperature. Repeat UGIE revealed no active bleeding source and confirmed obliteration of the previously detected varices. Evaluation identified deficiencies in protein S, protein C, and antithrombin III, for which anticoagulation with enoxaparin was initiated. Despite recent sclerotherapy, anticoagulation precipitated melena. Sigmoidoscopy and capsule endoscopy revealed portal hypertensive colopathy with rectal varices. This was managed surgically by creating mesocaval shunts after which enoxaparin was restarted. No further recurrence of bleeding occurred; the patient was discharged in a stable condition.
This case highlighted the importance of thorough coagulation profiling in extrahepatic portal venous obstruction, particularly in young patients with recurrent thrombotic events. Clinicians must navigate the precarious balance between thrombosis prevention and hemorrhage risk.
Core Tip: Extrahepatic portal venous obstruction (EHPVO) is a leading cause of non-cirrhotic portal hypertension in young individuals. It is linked to procoagulable states; however, combined anticoagulant deficiencies are rare. This case described a 27-year-old adult with long-standing EHPVO complicated by recurrent thrombotic and hemorrhagic events in the setting of combined deficiencies of protein S, protein C, and antithrombin III. It highlighted the diagnostic uncertainty in distinguishing between acquired and inherited anticoagulant deficiencies in chronic portal vein thrombosis and underscored the clinical challenge of balancing anticoagulation against the risk of bleeding in EHPVO.
